Although significant progress has been made in systemic treatments, pancreatic cancer (PC) still remains the fourth leading cause of cancer-related deaths in the United States with an estimated 42,470 ...
You do not currently have access to this content.
Abstract. Previously, we reported on a series of highly potent, selective, and non-covalent CDK7 inhibitors that demonstrated antiproliferative activity against triple-negative breast cancer (TNBC) ...
Cancer Res (2026) 86 (8_Supplement): CT184.
Annual Meeting 2025 AACR Journals Simultaneous Publications | American Association for Cancer Research AACR Annual Meeting 2025: AACR Journals’ Concurrent Publications These journal articles published ...
Annual Meeting 2026 AACR Journals Simultaneous Publications | American Association for Cancer Research AACR Annual Meeting 2026: AACR Journals’ Simultaneous Publications These AACR journal articles ...
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
Loss of the mRNA m 6 A-binding protein YTHDF1 in dendritic cells enhances antitumor immunity. Major finding: Loss of the mRNA m 6 A-binding protein YTHDF1 in dendritic cells enhances antitumor ...
Clin Cancer Res (2009) 15 (13): 4446–4452. Purpose: Multiplexing assay of biomarkers at the point-of-care is an elusive goal for molecular diagnostics. Experimental Design: Here, we report an ...
1Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.
1Department of Thoracic Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou, China. 2Yangzhou Key Laboratory of Thoracic and Cardiac Surgery, Yangzhou, China.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results